experimentica Profile Banner
Experimentica Profile
Experimentica

@experimentica

Followers
77
Following
15
Media
149
Statuses
194

A global ophthalmic contract research organization headquartered in Kuopio, Finland.

Finland
Joined December 2014
Don't wanna be here? Send us removal request.
@experimentica
Experimentica
7 months
RT @NeoVasculo: Great achievement in neovascularization research by our Consortium Partner, @experimentica !.#Experimentica #ExperimenticaS….
0
1
0
@experimentica
Experimentica
1 year
Jeff Jamison and Guillaume Demarne will be in Boston next week for the 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit!. Book a meeting with us there. Not attending? Book a later Teams call. #wetAMD #DiabeticRetinopathy
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
Meet us at BioFIT in Marseille, France for our last meeting of 2023! Let's discuss about your preclinical ocular drug development programs and needs for 2024. Not attending BioFIT?. Book a Teams meeting. #Experimentica #Event.
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
[PRESENTATION] Animal Models for Dry AMD Therapeutic Development | 4th Dry AMD Drug Development Summit | Boston, Nov 14-17, 2023. Jeff Jamison, Experimentica’s CDO, shares his take on relevant in vivo models of dry AMD. Program:. #Experimentica #dryAMD
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
[SAVE THE DATE] Join us at 4th Dry AMD Drug Development Summit in Boston, MA, from November 14-17, 2023. Full Program here:. Not attending? Schedule a Teams meeting with us:. #Experimentica #Event #dryamd
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
We want to hear about your preclinical ocular drug developments! Meet with us at Bio-Europe 2023 on Nov 7-8, 2023. Not attending Bio-Europe?. Book a Teams meeting. #Experimentica #Event.
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
Join us at Eyecelerator 2023 in SF, CA on November 2, 2023. Connect with Giedrius Kalesnykas, Guillaume Demarne, and Jeff Jamison to explore your ocular drug development programs. Can't make it in person? Let's schedule a Teams meeting. #Eyecelerator2023
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
[CONFERENCE] 4th Annual Gene Therapy for Ophthalmic Disorders conference, Boston, October 4-5, 2023. Guillaume Demarne and Jeff Jamison will meet with you to discuss your ocular GTx programs. Not attending? Schedule a Teams meeting:. #Experimentica #Event
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
[POSTER] Effect of Pertussis toxin and CFA on Meibomian gland function and secretion. Dr. Marianna Bacellar-Galdino will present at ACVO's Conference. Abstract. Interest in rabbit MGD? Schedule a meeting. #Experimentica #Event
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
[CONFERENCE] Experimentica’s Director of Veterinary Ophthalmology will attend ACVO's 54th Annual Scientific Conference in Boston on Sept 20-23, 2023. Program:. Not attending ? Schedule an online meeting:. #Experimentica #Event
Tweet media one
0
0
0
@experimentica
Experimentica
2 years
[CONFERENCE] Our team is gearing up for Life Sciences Baltics 2023! Meet us in Vilnius and discuss how we can support your preclinical studies in Ophthalmology. Not attending? Schedule online meeting. #Experimentica #Event
Tweet media one
0
0
1
@experimentica
Experimentica
2 years
[EVENT] Experimentica Science Day - Pharmaceutical Drug Delivery: Lessons from Ophthalmology | May 26, 2023, Vilnius, LT. Programme and free Registration. #Experimentica #Event #10years
Tweet media one
0
0
1
@experimentica
Experimentica
2 years
[ABSTRACT] Recombinant human PRG4 alleviates signs of allergic conjunctivitis in vivo. Authors: Iqbal S, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
1
1
@experimentica
Experimentica
2 years
[ABSTRACT] Subconjunctival administration of Aflibercept protects against neovascularization in the mouse CNV model. Authors: Cerrada-Gimenez M, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
1
1
@experimentica
Experimentica
2 years
[ABSTRACT] Aflibercept exerts structural protection against diabetic retinopathy – associated inner retinal abnormalities in the mouse STZ model. Authors: Ragauskas S, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
1
1
@experimentica
Experimentica
2 years
[ABSTRACT] Efficacy of topical ketotifen and prednisolone in the rabbit 48/80 model for allergic conjunctivitis. Authors: Pappenhagen NE, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
1
1
@experimentica
Experimentica
2 years
[PRESS RELEASE] Experimentica Ltd. Announces Strategic Expansion of Management Team with Three Key Appointments. This will bolster Experimentica’s Leadership team, driving Innovation and growth in preclinical ocular models. Full PR:. #Experimentica
Tweet media one
0
2
2
@experimentica
Experimentica
2 years
[ABSTRACT] AAV-mediated expression of human VEGF-A as a novel rat model of diabetic retinopathy. Authors: Lelyte I, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
1
1
@experimentica
Experimentica
2 years
[ABSTRACT] Involvement of thioredoxin system in laser-induced CNV mouse model. Authors: Cesna R, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
1
1
@experimentica
Experimentica
2 years
[ABSTRACT] Environmental particulate matter of different sizes leads to differential damage of the ocular surface. Authors: Ghosh AK, et al. All ARVO 2023 abstracts:. #Experimentica #Event
Tweet media one
0
2
3